Structures of ADP-ribosylated rifampicin and its metabolite: Intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756

Journal of Antibiotics

Volumn 53, Issue 3, 2000, Pages 269-275

  Morisaki, Naoko ^a   Hashimoto, Yuichi ^a   Furihata, Kazuo ^a   Imai, Tamae ^b   Watanabi, Kayo ^b   Mikami, Yuzuru ^b   Yazawa, Katsukiyo ^b   Ando, Akikazu ^b   Nagata, Yoshiho ^b   Dabbs, Eric R ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; DRUG METABOLITE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RIFAMPICIN; RIFAMPICIN DERIVATIVE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG INACTIVATION; DRUG STRUCTURE; ESCHERICHIA COLI; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; GENETIC TRANSFECTION; MOLECULAR WEIGHT; MYCOBACTERIUM SMEGMATIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

MYCOBACTERIUM SMEGMATIS;

EID: 0034032263     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.269     Document Type: Article

References (21)

1. MAGGI, N.; C. R. PASQUALUCCI, R. BALLOTTA & P. SENSI: Rifampicin: A new orally active rifamycin. Chemotherapia 11: 285-292, 1966
2. FURESZ, S.: Chemical and biological properties of rifampicin. Antibiot. Chemother. 16: 316-351, 1970
3. LANCINI, G. & W. ZANICHELLI: Structure-activity relationships in rifamycins. In Structure-Activity Relationships among the Semisynthetic Antibiotics. Ed., D. PERUMAN, pp. 531-600, Academic Press, 1977
4. WILLIAMS, D. L.; C. WAGUESPACK, K. EISENACH, J. T. CRAWFORD, F. PORTAELS, M. SALFINGER, C. M. NOLAN, C. ABE, V. STICHT-GROH & T. P. GILLIS: Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agent Chemother. 38: 2380-2386, 1994
5. YAZAWA, K.; Y. MIKAMI, A. MAEDA, M. AKAO, N. MORISAKI & S. IWASAKI: Inactivation of rifampin by Nocardia brasiliensis. Antimicrob. Agents Chemother. 37: 1313-1317, 1993
6. MORISAKI, N.; S. IWASAKI, K. YAZAWA, Y. MIKAMI & A. MAEDA: Inactivated products of rifampicin by pathogenic Nocardia spp.: Structures of glycosylated and phosphorylated metabolites of rifampicin and 3-formylrifamycin SV. J. Antibiotics 46: 1605-1610, 1993
7. YAZAWA, K.; Y. MIKAMI, A. MAEDA, N. MORISAKI & S. IWASAKI: Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J. Antimicrob. Chemother. 33: 1127-1135, 1994
8. TANAKA, Y.; K. YAZAWA, E. R. DABBS, K. NISHIKAWA, H. KOMAKI, Y. MIKAMI, M. MIYAZI, N. MORISAKI & S. IWASAKI: Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol. Immunol. 40: 1-4, 1996
9. DABBS, E. R.; K. YAZAWA, Y. TANAKA, Y. MIKAMI, M. MIYAJI, S. J. ANDERSEN, N. MORISAKI, S. IWASAKI, O. SHIDA, H. TAKAGI & K. KADOWAKI: Rifampicin inactivation by Bacillus species. J. Antibiotics 48: 815-819, 1995
10. DABBS, E. R.: Rifampicin inactivation by Rhodococcus and Mycobacterium species. FEMS Microbiol. Lett. 44: 395-399, 1987
11. ANDERSEN, S. J. & E. R. DABBS: Cloning of nocardioform DNA conferring the ability to inactivate rifampicin. FEMS Microbiol. Lett. 79: 247-250, 1991
12. DABBS, E. R.; K. YAZAWA, Y. MIKAMI, M. MIYAJI, N. MORISAKI, S. IWASAKI & K. FURIHATA: Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob. Agents Chemother. 39: 1007-1009, 1995
13. MORISAKI, N.; H. KOBAYASHI, S. IWASAKI, K. FURIHATA, E. R. DABBS, K. YAZAWA & Y. MIKAMI: Structure determination of ribosylated rifampicin and its derivative: New inactivated metabolites of rifampicin by micobacterial strains. J. Antibiotics 48: 1299-1303, 1995
14. QUAN, S.; H. VENTER & E. R. DABBS: Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Antimicrob. Agents Chemother. 41: 2456-2460, 1997
15. QUAN, S.; T. IMAI, Y. MIKAMI, K. YAZAWA, E. R. DABBS, N. MORISAKI, S. IWASAKI, Y. HASHIMOTO & K. FURIHATA: ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene. Antimicrob. Agents Chemother. 43: 181-184, 1999
16. IMAI, T.; K. WATANABE, Y. MIKAMI, K. YAZAWA, A. ANDO, Y. NAGATA, N. MORISAKI, Y. HASHIMOTO, K. FURIHATA & E. R. DABBS: Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatis. Microbial Drug Resistance 5: 259-264, 1999
17. 2O were also similar.
18. 13C nuclear-magnetic-resonance study of the enzyme cofactor flavin-adenine dinucleotide. Eur. J. Biochem, 31: 234-238, 1972
19. +. Biochim. Biophys. Acta 1076: 49-60, 1991
20. MORISAKI, N.; S. IWASAKI, K. FURIHATA, K. YAZAWA & Y. MIKAMI: Structural elucidation of rokitamycin, midecamycin and erythromycin metabolites formed by pathogenic Nocardia. Magn. Reson. Chem. 33: 481-389, 1995
21. +. J. Biochem. 97: 1263-1271, 1985